ストックスクリーナーアプリを入手
2.58
3.01%
-0.08
60 Degrees Pharmaceuticals Inc (SXTP) 最新ニュース
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines - Quantisnow
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation - The Manila Times
60 Degrees Pharmaceuticals, Inc. Reports 55% Increase in Q1 2025 Net Product Revenues to $163.6 Thousand - Nasdaq
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results - The Globe and Mail
60 DEGREES PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView
AST SpaceMobile (ASTS) Expected to Announce Earnings on Wednesday - Defense World
60 Degrees Pharmaceuticals (SXTP) to Release Quarterly Earnings on Wednesday - Defense World
KORE Group (KORE) to Release Quarterly Earnings on Thursday - Defense World
SPAR Group (SGRP) Expected to Announce Earnings on Wednesday - Defense World
Society Pass (SOPA) Projected to Post Quarterly Earnings on Wednesday - Defense World
Windtree Therapeutics (WINT) to Release Earnings on Wednesday - Defense World
Spero Therapeutics (SPRO) to Release Earnings on Wednesday - Defense World
StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN) - Defense World
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Spartan Delta Corp. (TSE:SDE) Given Average Recommendation of “Strong Buy” by Analysts - Defense World
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
National Bank Financial Weighs in on TSE:ATD FY2025 Earnings - Defense World
FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald - Defense World
Evoke Pharma (EVOK) to Release Earnings on Tuesday - Defense World
Legend Biotech (LEGN) Expected to Announce Earnings on Tuesday - Defense World
Best Green Energy Stocks To Research – May 9th - Defense World
PTC Therapeutics (NASDAQ:PTCT) Raised to Strong-Buy at StockNews.com - Defense World
Denny’s Co. (NASDAQ:DENN) Shares Sold by Barclays PLC - Defense World
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $83.25 - Defense World
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq
Raymond James Financial Inc. Makes New Investment in NETSTREIT Corp. (NYSE:NTST) - Defense World
60 Degrees Pharmaceuticals Announces 2024 Annual Results - ADVFN
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - ADVFN
60 Degrees Pharmaceuticals (SXTP) Unveils Discrepancies in Babes - GuruFocus
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
60 Degrees Pharmaceuticals Inc (SXTP) Stock: A Comprehensive 52-Week Review - investchronicle.com
60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
How is SXTP’s stock performing after recent trades? - uspostnews.com
Shocking Gap: Survey Finds 3 Million Babesiosis Cases While CDC Reports Only 1,834Major Market Opportunity - Stock Titan
Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey - Yahoo Finance
Form 8-KCurrent report - ADVFN
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - ADVFN
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Short Interest Down 43.2% in March - Defense World
Deal Watch: Oak Hill Picks Up Where Roche Left Off In Angelman Syndrome - insights.citeline.com
Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday? - MSN
60 Degrees Pharma's Breakthrough: New Clinical Trials Target Rising Tick-Borne Disease Crisis - Stock Titan
10 Stocks Fall Behind Amid Market Optimism - Insider Monkey
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
60 Degrees and Yale to progress tafenoquin for babesiosis - Yahoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
60 Degrees Pharmaceuticals (SXTP) Reports 2024 Financial Results - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Announces 1-for-5 Reverse Stoc - GuruFocus
60 Degrees Pharma signs patent agreement with Yale for tick disease medicine development - Mugglehead Magazine
60 Degrees Pharmaceuticals signs Patient License Agreement with Yale - TipRanks
TNF Pharmaceuticals Inc: Navigating Market Fluctuations with a 0.75M Market Cap - investchronicle.com
How Rigetti's 2024 Quantum Dreams Turned Into 2025 Nightmares - Yahoo
60 Degrees Pharmaceuticals partners with Yale for drug development By Investing.com - Investing.com South Africa
Why Lucid Stock Plunged 20% in Q1 as the Nasdaq Fell 10% - Yahoo
Elegant boutique Detroit hotel, The Siren, sued by Huntington bank over loan - yahoo.com
Traders boost bets Fed will start cutting rates in May - Yahoo Finance
AAN 2025: J&J reveals data for nipocalimab, showing long-term disease control in MG - Yahoo
Mr. Yoshida's Brings the Heat with New Spicy Wing & Rib Sauce - Yahoo Finance
InventHelp Inventor Develops New Litter Removal Tool for Poultry Houses (JTK-236) - Yahoo Finance
Big Lots announces some stores will reopen. A Kentucky location will reopen this week - Yahoo Finance
60 Degrees Pharmaceuticals (SXTP) Stock Rallies On Tafenoquine Patent News - Stocks Telegraph
RPM International Stock Drops on DayGlo Parent's Weaker-Than-Expected Results - Yahoo
Will Assurant (AIZ) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Donaldson Exhibits Strong Prospects Despite Persisting Headwinds - Yahoo Finance
1.89%
3.74%
大文字化:
|
ボリューム (24 時間):